FDA reviewing safety of abortion drug mifepristone
Summary
The Food and Drug Administration (FDA) is reviewing the safety of the abortion pill mifepristone. This review could lead to new rules from President Trump's administration that limit how the drug is used and distributed.Key Facts
- The FDA is conducting a safety review of mifepristone, a drug used to end early pregnancies.
- The review follows a request from groups opposed to abortion.
- The review might result in tighter restrictions on who can get the drug and how it is provided.
- President Donald Trump’s administration is involved in deciding the future rules on this drug.
- Mifepristone has been used as part of medical abortion procedures for several years.
- Anti-abortion groups view the review as a chance to reduce access to abortion pills.
- The FDA's process includes looking at data from past use of the drug.
- The decision could impact abortion access in the United States.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.